Comparison of serum amylase level between dipeptidyl peptidase-4 inhibitor and GLP-1 analog administration in patients with type 2 diabetes mellitus

Junichi Okada, Eijiro Yamada, Yawara Niijima, Shuichi Okada, Masanobu Yamada

Open source

DOI
10.1186/s41043-019-0197-x
Published
2019-11-14
Container
Journal of Health, Population and Nutrition
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s41043-019-0197-x,
  title = {Comparison of serum amylase level between dipeptidyl peptidase-4 inhibitor and GLP-1 analog administration in patients with type 2 diabetes mellitus},
  author = {Junichi Okada and Eijiro Yamada and Yawara Niijima and Shuichi Okada and Masanobu Yamada},
  year = {2019},
  journal = {Journal of Health, Population and Nutrition},
  doi = {10.1186/s41043-019-0197-x},
  url = {https://doi.org/10.1186/s41043-019-0197-x}
}

RIS

TY  - JOUR
TI  - Comparison of serum amylase level between dipeptidyl peptidase-4 inhibitor and GLP-1 analog administration in patients with type 2 diabetes mellitus
AU  - Junichi Okada
AU  - Eijiro Yamada
AU  - Yawara Niijima
AU  - Shuichi Okada
AU  - Masanobu Yamada
PY  - 2019
JO  - Journal of Health, Population and Nutrition
DO  - 10.1186/s41043-019-0197-x
UR  - https://doi.org/10.1186/s41043-019-0197-x
ER  - 

APA

Okada, J., Yamada, E., Niijima, Y., Okada, S., & Yamada, M. (2019). Comparison of serum amylase level between dipeptidyl peptidase-4 inhibitor and GLP-1 analog administration in patients with type 2 diabetes mellitus. Journal of Health, Population and Nutrition. https://doi.org/10.1186/s41043-019-0197-x

Source records